Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

References for PMC Articles for PubMed (Select 20019241)

1.

Vaccinia virus vaccines: past, present and future.

Jacobs BL, Langland JO, Kibler KV, Denzler KL, White SD, Holechek SA, Wong S, Huynh T, Baskin CR.

Antiviral Res. 2009 Oct;84(1):1-13. doi: 10.1016/j.antiviral.2009.06.006. Epub 2009 Jun 26. Review.

2.

Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.

Waibler Z, Anzaghe M, Frenz T, Schwantes A, Pöhlmann C, Ludwig H, Palomo-Otero M, Alcamí A, Sutter G, Kalinke U.

J Virol. 2009 Feb;83(4):1563-71. doi: 10.1128/JVI.01617-08. Epub 2008 Dec 10.

3.

Monkeypox virus and insights into its immunomodulatory proteins.

Weaver JR, Isaacs SN.

Immunol Rev. 2008 Oct;225:96-113. doi: 10.1111/j.1600-065X.2008.00691.x. Review.

4.

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses.

Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K, Staeheli P.

PLoS Pathog. 2008 Sep 12;4(9):e1000151. doi: 10.1371/journal.ppat.1000151.

5.

Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.

Earl PL, Americo JL, Wyatt LS, Espenshade O, Bassler J, Gong K, Lin S, Peters E, Rhodes L Jr, Spano YE, Silvera PM, Moss B.

Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10889-94. doi: 10.1073/pnas.0804985105. Epub 2008 Aug 4.

6.

Comparative analysis of viral gene expression programs during poxvirus infection: a transcriptional map of the vaccinia and monkeypox genomes.

Rubins KH, Hensley LE, Bell GW, Wang C, Lefkowitz EJ, Brown PO, Relman DA.

PLoS One. 2008 Jul 9;3(7):e2628. doi: 10.1371/journal.pone.0002628.

7.

Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons.

Mann BA, Huang JH, Li P, Chang HC, Slee RB, O'Sullivan A, Anita M, Yeh N, Klemsz MJ, Brutkiewicz RR, Blum JS, Kaplan MH.

J Interferon Cytokine Res. 2008 Jun;28(6):367-80. doi: 10.1089/jir.2007.0113.

8.

The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.

Xu RH, Cohen M, Tang Y, Lazear E, Whitbeck JC, Eisenberg RJ, Cohen GH, Sigal LJ.

J Exp Med. 2008 Apr 14;205(4):981-92. doi: 10.1084/jem.20071854. Epub 2008 Apr 7.

9.

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity.

Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR.

J Immunol. 2008 Feb 15;180(4):2474-85.

10.

Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.

Yadav VN, Pyaram K, Mullick J, Sahu A.

J Virol. 2008 Apr;82(7):3283-94. doi: 10.1128/JVI.01935-07. Epub 2008 Jan 23.

11.
12.

Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus.

Huang J, Smirnov SV, Lewis-Antes A, Balan M, Li W, Tang S, Silke GV, Pütz MM, Smith GL, Kotenko SV.

Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9822-7. Epub 2007 May 21.

14.

Zoonotic vaccinia virus infection in Brazil: clinical description and implications for health professionals.

de Souza Trindade G, Drumond BP, Guedes MI, Leite JA, Mota BE, Campos MA, da Fonseca FG, Nogueira ML, Lobato ZI, Bonjardim CA, Ferreira PC, Kroon EG.

J Clin Microbiol. 2007 Apr;45(4):1370-2. Epub 2007 Feb 7.

15.

Immunopathogenesis of poxvirus infections: forecasting the impending storm.

Stanford MM, McFadden G, Karupiah G, Chaudhri G.

Immunol Cell Biol. 2007 Feb-Mar;85(2):93-102. Epub 2007 Jan 16. Review.

PMID:
17228320
16.

Interferon signalling network in innate defence.

Takaoka A, Yanai H.

Cell Microbiol. 2006 Jun;8(6):907-22. Review.

PMID:
16681834
17.

A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus.

Alejo A, Ruiz-Argüello MB, Ho Y, Smith VP, Saraiva M, Alcami A.

Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5995-6000. Epub 2006 Mar 31.

18.

Reemergence of monkeypox: prevalence, diagnostics, and countermeasures.

Nalca A, Rimoin AW, Bavari S, Whitehouse CA.

Clin Infect Dis. 2005 Dec 15;41(12):1765-71. Epub 2005 Nov 11. Review.

19.

Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.

Bartlett NW, Buttigieg K, Kotenko SV, Smith GL.

J Gen Virol. 2005 Jun;86(Pt 6):1589-96.

20.

The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.

Rubins KH, Hensley LE, Jahrling PB, Whitney AR, Geisbert TW, Huggins JW, Owen A, Leduc JW, Brown PO, Relman DA.

Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15190-5. Epub 2004 Oct 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk